Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 33
Filter
1.
Medicine (Baltimore) ; 100(47): e27919, 2021 Nov 24.
Article in English | MEDLINE | ID: mdl-34964763

ABSTRACT

BACKGROUND: There is a heated debate on the clinicopathological features and prognostic significance with non-metastasis 23 (NM23) expression in patients with non-small cell lung cancer (NSCLC). Thus, we conducted this meta-analysis to evaluate the clinicopathological features and prognostic significance of NM23 for NSCLC patients. METHODS: Pubmed, Embase, and Web of Science were exhaustively searched to identify relevant studies published prior to March, 2020. Odds radios (ORs) and hazard radios with 95% confidence intervals (CIs) were calculated to summarize the statistics of clinicopathological and prognostic assessments. Q-test and I2-statistic were utilized to assess heterogeneity across the included studies. We also performed subgroup analyses and meta-regression analyses to identify the source of heterogeneity. Publication bias was detected by Begg and Egger tests. Sensitivity analysis was used to value the stability of our results. All the data were analyzed using statistical packages implemented in R version 4.0.5. RESULTS: Data from a total of 3170 patients from 36 studies were extracted. The meta-analysis revealed that low expression of NM23 was correlated with higher risk of NSCLC (OR = 4.35; 95% CI: 2.76-6.85; P < .01), poorer tumor node metastasis (TNM) staging (OR = 1.39; 95% CI: 1.01-1.90; P = .04), poorer differentiation degree (OR = 1.37; 95% CI: 1.01-1.86; P = .04), positive lymph node metastasis (OR = 1.83; 95% CI: 1.22-2.74; P < .01), lung adenocarcinoma (OR = 1.45; 95% CI: 1.20-1.75; P < .01), and poorer 5-year overall survival (OS) rate (hazard radio = 2.33; 95%CI: 1.32-4.11; P < .01). The subgroup analyses and meta-regression analyses suggested that the "Publication year", "Country", "Sample size", and "Cutoff value" might be the source of heterogeneity in TNM staging, differentiation degree, and lymph node metastasis. Both Begg test and Egger test verified that there were publication bias in 5-year OS rate. Sensitivity analysis supported the credibility of the results. CONCLUSION: The reduced NM23 expression is strongly associated with higher risk of NSCLC, higher TNM staging, poorer differentiation degree, positive lymph node metastasis, lung adenocarcinoma, and poorer 5-year OS rate in NSCLC patients, which indicated that NM23 could serve as a biomarker predicating the clinicopathological and prognostic significance of NSCLC.


Subject(s)
Adenocarcinoma of Lung/pathology , Biomarkers, Tumor/analysis , Carcinoma, Non-Small-Cell Lung/pathology , Lung Neoplasms/pathology , NM23 Nucleoside Diphosphate Kinases/analysis , Humans , Lymphatic Metastasis , Neoplasm Grading , Neoplasm Staging , Prognosis
2.
Biochem Biophys Res Commun ; 516(1): 50-56, 2019 08 13.
Article in English | MEDLINE | ID: mdl-31196624

ABSTRACT

Compartmentalization is vital for biological systems at multiple levels, including biochemical reactions in metabolism. Organelle-based compartments such as mitochondria and peroxisomes sequester the responsible enzymes and increase the efficiency of metabolism while simultaneously protecting the cell from dangerous intermediates, such as radical oxygen species. Recent studies show intracellular nucleotides, such as ATP and GTP, are heterogeneously distributed in cells with high concentrations at the lamellipodial and filopodial projections, or leading edge. However, the intracellular distribution of purine nucleotide enzymes remains unclear. Here, we report the enhanced localization of GTP-biosynthetic enzymes, including inosine monophosphate dehydrogenase (IMPDH isotype 1 and 2), GMP synthase (GMPS), guanylate kinase (GUK1) and nucleoside diphosphate kinase-A (NDPK-A) at the leading edge in renal cell carcinoma cells. They show significant co-localization at the membrane subdomain, and their co-localization pattern at the membrane is distinct from that of the cell body. While other purine nucleotide biosynthetic enzymes also show significant localization at the leading edge, their co-localization pattern with IMPDH is divergent. In contrast, a key glycolytic enzyme, glyceraldehyde-3-phosphate dehydrogenase (GAPDH), predominantly localized in the cytoplasm. Mechanistically, we found that plasma membrane localization of IMPDH isozymes requires active actin polymerization. Our results demonstrate the formation of a discrete metabolic compartment for localized purine biosynthesis at the leading edge, which may promote localized nucleotide metabolism for cell migration and metastasis in cancers.


Subject(s)
Carcinoma, Renal Cell/enzymology , Kidney Neoplasms/enzymology , Purine Nucleotides/metabolism , Carbon-Nitrogen Ligases/analysis , Carbon-Nitrogen Ligases/metabolism , Carcinoma, Renal Cell/metabolism , Carcinoma, Renal Cell/pathology , Cell Line, Tumor , Guanylate Kinases/analysis , Guanylate Kinases/metabolism , Humans , IMP Dehydrogenase/analysis , IMP Dehydrogenase/metabolism , Kidney Neoplasms/metabolism , Kidney Neoplasms/pathology , NM23 Nucleoside Diphosphate Kinases/analysis , NM23 Nucleoside Diphosphate Kinases/metabolism
3.
Int J Surg ; 60: 257-265, 2018 Dec.
Article in English | MEDLINE | ID: mdl-30389538

ABSTRACT

OBJECTIVE: Extensive studies have been carried out to investigate the association between nm23 expression and the prognosis and clinicopathologic significance of various tumors. METHODS AND MATERIALS: Eligible studies were searched from Embase, China National Knowledge Infrastructure (CNKI), PubMed and Web of Science up to May 2017. In this study, we calculated the pooled hazard ratios (HRs) with 95% confidence intervals (95%CIs) to determine the association between nm23 expression and the prognosis of various tumors. RESULTS: A total of 49 studies were finally included in the meta-analysis. The pooled HRs were 2.00 (95% CIs: 1.44-2.78) for overall survival (OS), 1.23 (95% CIs: 1.04-1.46) for disease-specific survival or progression-free survival (DFS/PFS), and 2.21 (95% CIs: 1.38-3.57) for survival of recurrence-free survival or metastasis-free survival (RFS/MFS). Moreover, the results indicated that low nm23 expression was significantly correlated with the lymph node metastasis (P = 0.002). For the subgroup analysis, the expression of nm23 in patients at N0 stage was obviously higher than the patients with breast carcinoma at N1-N3 stage [Odds ratio (OR) = 2.07, 95%CI (1.31, 3.26), P = 0.002]. Moreover, the expression of nm23 in the patients at N0 stage was remarkably higher than those at N1-N3 stages in the Chinese patients with breast carcinoma and those with nasopharyngeal carcinoma (P < 0.05). Whereas, no statistical difference was noticed in the expression of nm23 in patients of various age, gender, T stage, histological degree, TNM stage, respectively (P > 0.05). CONCLUSION: Our study suggests that down-regulation of nm23 is related to poor prognosis in many cancers. The expression of nm23 in cancer tissues may serve as an important factor for evaluating the presence of lymph node metastasis.


Subject(s)
Breast Neoplasms/pathology , NM23 Nucleoside Diphosphate Kinases/analysis , Breast Neoplasms/chemistry , Breast Neoplasms/mortality , Female , Humans , Lymphatic Metastasis , Neoplasm Staging , Prognosis
4.
FEBS J ; 285(15): 2856-2868, 2018 08.
Article in English | MEDLINE | ID: mdl-29863788

ABSTRACT

Nm23/NME was identified 30 years ago as the first metastatic gene suppressor family. Despite extensive studies, the mechanism of action behind the observed antimetastatic potential of Nm23 has remained largely unresolved. Human Nm23 is present in various isoforms, of which Nm23-H1 and Nm23-H2 are by far the most dominant. Both isoforms are multifunctional enzymes involved in important cellular processes, through their nucleic acid binding ability, their protein-protein interactions and/or their histidine kinase activity. Although Nm23-H1 and Nm23-H2 exhibit 88% sequence homology, they often are considered to have distinct biological functions. Here, we developed an efficient and robust purification protocol to pull-down Nm23 isoforms in their native state. We applied this protocol to purify both overexpressed isoform pure as well as endogenous Nm23 proteins from several human cell lines and mouse brain tissue. Subsequent native mass spectrometry (MS) analysis revealed that all purified Nm23 samples form hexamers, whereby the endogenous protein assembly is primarily present as heterohexamers formed by statistical association of the Nm23-H1 and Nm23-H2 isoforms. Therefore, we conclude that isoform-pure hexameric Nm23 complexes scarcely exist in vivo. We also used native and top-down MS to investigate the histidine autophosphorylation activity of purified Nm23 assemblies. Our data in fine challenge the biological relevance of studying the genes/proteins Nm23-H1 and Nm23-H2 individually.


Subject(s)
Mass Spectrometry/methods , NM23 Nucleoside Diphosphate Kinases/isolation & purification , HEK293 Cells , Humans , NM23 Nucleoside Diphosphate Kinases/analysis , NM23 Nucleoside Diphosphate Kinases/metabolism , Phosphorylation , Protein Isoforms/analysis , Protein Isoforms/isolation & purification , Protein Isoforms/metabolism
5.
Methods Mol Biol ; 1765: 241-269, 2018.
Article in English | MEDLINE | ID: mdl-29589313

ABSTRACT

Nowadays, the ideal biomarker for colorectal cancer (CRC) has not been found. Two-dimensional electrophoresis (2-DE) and mass spectrometry (MS) are suitable techniques for searching new biomarkers. In this chapter, we describe methodology for biomarker discovery based on a proteomic approach. In addition, special attention is given to the sample preparation, including protein extraction, fractionation, and cleanup, as we consider this a critical step. Comparing the proteomic profile of tumor and mucosa, we identified the nucleoside diphosphate kinase A (NDKA) protein as a candidate biomarker for CRC. Finally, we validated NDKA with an ELISA kit using serum samples from individuals of a screening cohort. Our results suggest that serum NDKA is a potential biomarker for screening of CRC and premalignant advanced adenomas (AA).


Subject(s)
Adenoma/diagnosis , Biomarkers, Tumor/analysis , Colorectal Neoplasms/diagnosis , NM23 Nucleoside Diphosphate Kinases/analysis , Proteomics/methods , Adenoma/blood , Biomarkers, Tumor/metabolism , Blotting, Western/instrumentation , Blotting, Western/methods , Colon/pathology , Colorectal Neoplasms/blood , Colorectal Neoplasms/pathology , Electrophoresis, Polyacrylamide Gel/instrumentation , Electrophoresis, Polyacrylamide Gel/methods , Enzyme-Linked Immunosorbent Assay/instrumentation , Enzyme-Linked Immunosorbent Assay/methods , Humans , Intestinal Mucosa/pathology , Mass Spectrometry/instrumentation , Mass Spectrometry/methods , NM23 Nucleoside Diphosphate Kinases/metabolism , Proteome/analysis , Proteome/metabolism , Proteomics/instrumentation , Rectum/pathology , Software
6.
Anal Chim Acta ; 973: 82-90, 2017 Jun 22.
Article in English | MEDLINE | ID: mdl-28502431

ABSTRACT

Nucleoside diphosphatase kinase A (NDPK-A) is a metastasis-suppressor protein and a biomarker that act on a wide range cancer cells to inhibit the potential metastasis. Herein, we present a simple photoelectrochemical immunosensor based on ZnO nanorod arrays for the sensitive detection of NDPK-A. The ZnO nanorod arrays cosensitized with CdS nanoparticles and Mn2+ displayed a high and stable photocurrent response under irradiation. After anti-NPDK-A nanobodies were immobilized to the ZnO nanorod arrays, the proposed immunosensor can be utilized for detecting NPDK-A by monitoring the changes in the photocurrent signals of the electrode resulting from immunoreaction. Accordingly, the well-designed immunosensor exhibited a low limit of detection (LOD) of 0.3 pg mL-1 and a wide linear range from 0.5 pg mL-1 to 10 µg mL-1. The R2 of the regression curve is 0.99782. Meanwhile, the good stability, reproducibility and specificity of the resulting photoelectrochemical biosensor are demonstrated. In addition, the presented work would offer a novel and simple approach for the detection of immunoreactions and provide new insights in popularizing the diagnosis of NPDK-A.


Subject(s)
Biosensing Techniques , Electrochemical Techniques , NM23 Nucleoside Diphosphate Kinases/analysis , Nanotubes , Zinc Oxide , Humans , Immunoassay , NM23 Nucleoside Diphosphate Kinases/blood , Reproducibility of Results
7.
Circulation ; 135(9): 881-897, 2017 Feb 28.
Article in English | MEDLINE | ID: mdl-27927712

ABSTRACT

BACKGROUND: Chronic heart failure (HF) is associated with altered signal transduction via ß-adrenoceptors and G proteins and with reduced cAMP formation. Nucleoside diphosphate kinases (NDPKs) are enriched at the plasma membrane of patients with end-stage HF, but the functional consequences of this are largely unknown, particularly for NDPK-C. Here, we investigated the potential role of NDPK-C in cardiac cAMP formation and contractility. METHODS: Real-time polymerase chain reaction, (far) Western blot, immunoprecipitation, and immunocytochemistry were used to study the expression, interaction with G proteins, and localization of NDPKs. cAMP levels were determined with immunoassays or fluorescent resonance energy transfer, and contractility was determined in cardiomyocytes (cell shortening) and in vivo (fractional shortening). RESULTS: NDPK-C was essential for the formation of an NDPK-B/G protein complex. Protein and mRNA levels of NDPK-C were upregulated in end-stage human HF, in rats after long-term isoprenaline stimulation through osmotic minipumps, and after incubation of rat neonatal cardiomyocytes with isoprenaline. Isoprenaline also promoted translocation of NDPK-C to the plasma membrane. Overexpression of NDPK-C in cardiomyocytes increased cAMP levels and sensitized cardiomyocytes to isoprenaline-induced augmentation of contractility, whereas NDPK-C knockdown decreased cAMP levels. In vivo, depletion of NDPK-C in zebrafish embryos caused cardiac edema and ventricular dysfunction. NDPK-B knockout mice had unaltered NDPK-C expression but showed contractile dysfunction and exacerbated cardiac remodeling during long-term isoprenaline stimulation. In human end-stage HF, the complex formation between NDPK-C and Gαi2 was increased whereas the NDPK-C/Gαs interaction was decreased, producing a switch that may contribute to an NDPK-C-dependent cAMP reduction in HF. CONCLUSIONS: Our findings identify NDPK-C as an essential requirement for both the interaction between NDPK isoforms and between NDPK isoforms and G proteins. NDPK-C is a novel critical regulator of ß-adrenoceptor/cAMP signaling and cardiac contractility. By switching from Gαs to Gαi2 activation, NDPK-C may contribute to lower cAMP levels and the related contractile dysfunction in HF.


Subject(s)
Cyclic AMP/analysis , Heart Failure/pathology , NM23 Nucleoside Diphosphate Kinases/analysis , Animals , Cell Line , Cell Membrane/metabolism , Cyclic AMP/metabolism , Disease Models, Animal , Embryo, Nonmammalian/metabolism , GTP-Binding Protein alpha Subunits, G12-G13/metabolism , Heart Failure/metabolism , Humans , Isoproterenol/pharmacology , Male , Mice , Mice, Inbred C57BL , Mice, Knockout , Myocytes, Cardiac/cytology , Myocytes, Cardiac/drug effects , Myocytes, Cardiac/metabolism , NM23 Nucleoside Diphosphate Kinases/antagonists & inhibitors , NM23 Nucleoside Diphosphate Kinases/genetics , NM23 Nucleoside Diphosphate Kinases/metabolism , Protein Binding , Protein Isoforms/chemistry , Protein Isoforms/genetics , Protein Isoforms/metabolism , RNA Interference , RNA, Small Interfering/metabolism , Rats , Rats, Wistar , Zebrafish/growth & development
8.
Parasit Vectors ; 9(1): 641, 2016 12 13.
Article in English | MEDLINE | ID: mdl-27964761

ABSTRACT

BACKGROUND: Nucleoside diphosphate kinase b (NDKb) is responsible for nucleoside triphosphates synthesis and it has key role in the purine metabolism in trypanosomatid protozoans. Elongation factor 2 (EF2) is an important factor for protein synthesis. Recently, our phosphoproteomic analysis demonstrated that NDKb and EF2 proteins were phosphorylated and dephosphorylated in antimony (SbIII)-resistant L. braziliensis line compared to its SbIII-susceptible pair, respectively. METHODS: In this study, the overexpression of NDKb and EF2 genes in L. braziliensis and L. infantum was performed to investigate the contribution of these proteins in the SbIII-resistance phenotype. Furthermore, we examined the role of lamivudine on SbIII susceptibility in clones that overexpress the NDKb gene, and the effect of EF2 kinase (EF2K) inhibitor on the growth of EF2-overexpressing parasites. RESULTS: Western blot analysis demonstrated that NDKb and EF2 proteins are more and less expressed, respectively, in SbIII-resistant line of L. braziliensis than its wild-type (WTS) counterpart, corroborating our previous phosphoproteomic data. NDKb or EF2-overexpressing L. braziliensis lines were 1.6 to 2.1-fold more resistant to SbIII than the untransfected WTS line. In contrast, no difference in SbIII susceptibility was observed in L. infantum parasites overexpressing NDKb or EF2. Susceptibility assays showed that NDKb-overexpressing L. braziliensis lines presented elevated resistance to lamivudine, an antiviral agent, but it did not alter the leishmanicidal activity in association with SbIII. EF2-overexpressing L. braziliensis clone was slightly more resistant to EF2K inhibitor than the WTS line. Surprisingly, this inhibitor increased the antileishmanial effect of SbIII, suggesting that this association might be a valuable strategy for leishmaniasis chemotherapy. CONCLUSION: Our findings represent the first study of NDKb and EF2 genes overexpression that demonstrates an increase of SbIII resistance in L. braziliensis which can contribute to develop new strategies for leishmaniasis treatment.


Subject(s)
Antimony/toxicity , Drug Resistance , Leishmania braziliensis/drug effects , Leishmania braziliensis/genetics , NM23 Nucleoside Diphosphate Kinases/analysis , Peptide Elongation Factor 2/analysis , Blotting, Western , Gene Expression Profiling , Leishmania infantum/drug effects , Leishmania infantum/genetics , NM23 Nucleoside Diphosphate Kinases/genetics , Peptide Elongation Factor 2/genetics
9.
Analyst ; 141(15): 4733-41, 2016 Aug 07.
Article in English | MEDLINE | ID: mdl-27273166

ABSTRACT

Nucleoside diphosphate kinase from Leishmania spp. (LmNDKb) has recently been described as a potential drug target to treat leishmaniasis disease. Therefore, screening of LmNDKb ligands requires methodologies that mimic the conditions under which LmNDKb acts in biological systems. Here, we compare two label-free methodologies that could help screen LmNDKb ligands and measure NDKb activity: an offline LC-UV assay for soluble LmNDKb and an online two-dimensional LC-UV system based on LmNDKb immobilised on a silica capillary. The target enzyme was immobilised on the silica capillary via Schiff base formation (to give LmNDKb-ICER-Schiff) or affinity attachment (to give LmNDKb-ICER-His). Several aspects of the ICERs resulting from these procedures were compared, namely kinetic parameters, stability, and procedure steps. Both the LmNDKb immobilisation routes minimised the conformational changes and preserved the substrate binding sites. However, considering the number of steps involved in the immobilisation procedure, the cost of reagents, and the stability of the immobilised enzyme, immobilisation via Schiff base formation proved to be the optimal procedure.


Subject(s)
Chromatography, High Pressure Liquid , Leishmania/enzymology , NM23 Nucleoside Diphosphate Kinases/analysis , Enzymes, Immobilized , Kinetics , Ligands , Silicon Dioxide
10.
Medicine (Baltimore) ; 95(4): e2589, 2016 Jan.
Article in English | MEDLINE | ID: mdl-26825905

ABSTRACT

The clinical value of a prominent metastasis suppressor, nonmetastatic protein 23 (NM23), remains controversial. In this study, we examined the correlation between NM23 protein levels and the clinicopathologic features of colorectal cancers (CRC), and assessed the overall prognostic value of NM23 for CRC. Embase, PubMed, Web of Science, and other scientific literature databases were exhaustively searched to identify relevant studies published prior to June 31, 2015. The methodological qualities of selected studies were scored based on the critical appraisal skills program (CASP) criteria, as independently assessed by 2 reviewers. NM23 protein levels in tumor tissues of CRC patients were examined in relation to Dukes stage, differentiation grade, T-stage, lymph node metastasis status, and overall survival (OS). STATA software version 12.0 (Stata Corp, College Station, TX) was used for statistical analysis of data pooled from selected studies. Nineteen cohort studies met the inclusion criteria for present study and contained a combined total of 2148 study subjects. Pooled odd ratios (ORs) for NM23 expression revealed that reduced NM23 protein levels in CRC tumor tissues correlated with Dukes stage C and D (OR = 1.89, 95% CI: 1.06-3.39, P = 0.032), poor differentiation grades (OR = 1.41, 95% CI: 1.03-1.94, P = 0.032), and positive lymph node metastasis status (OR = 3.21, 95% CI: 1.95-5.29, P < 0.001). On the other hand, no such correlations were evident with T-stage T3-4 (OR = 1.56, 95% CI: 0.60-4.06, P = 0.367) or OS (OR = 0.79, 95% CI: 0.58-1.08, P = 0.138). Our analysis of pooled data found that NM23 expression is reduced in CRC tissues and low NM23 levels tightly correlate with higher Dukes stages, poorer differentiation grade, and positive lymph node metastases. However, NM23 levels did not influence the OS in CRC patients.


Subject(s)
Colorectal Neoplasms/chemistry , Colorectal Neoplasms/pathology , NM23 Nucleoside Diphosphate Kinases/analysis , Humans , Lymphatic Metastasis , Neoplasm Grading , Neoplasm Staging , Survival Rate
11.
Int J Dermatol ; 54(8): 905-15, 2015 Aug.
Article in English | MEDLINE | ID: mdl-25428551

ABSTRACT

BACKGROUND: Basal cell carcinomas (BCCs) are common malignant skin tumors. Despite having a significant invasion capacity, they metastasize only rarely. Our aim in this study was to detect the expression patterns of the NM23-H1, NDRG1, E-cadherin, RHOGDI2, CD82/KAI1, MKK4, and AKAP12 metastasis suppressor proteins in BCCs. METHODS: A total of 96 BCC and 10 normal skin samples were included for the immunohistochemical study. Eleven frozen BCC samples were also studied by quantitative real time polymerase chain reaction (qRT-PCR) to detect the gene expression profile. RESULTS: NM23-H1 was strongly and diffusely expressed in all types of BCC. Significant cytoplasmic expression of NDRG1 and E-cadherin was also detected. However, AKAP12 and CD82/KAI1 expression was significantly decreased. The expressions of the other proteins were somewhere between the two extremes. Similarly, qRT-PCR analysis showed down-regulation of AKAP12 and up-regulation of NM23-H1 and NDRG1 in BCC. Morphologically aggressive BCCs showed significantly higher cytoplasmic NDRG1 expression scores and lower CD82/KAI1 scores than non-aggressive BCCs. CONCLUSION: The relatively preserved levels of NM23-H1, NDRG1, and E-cadherin proteins may have a positive effect on the non-metastasizing features of these tumors.


Subject(s)
Carcinoma, Basal Cell/chemistry , Carcinoma, Basal Cell/genetics , Carcinoma, Basal Cell/metabolism , Skin Neoplasms/chemistry , Skin Neoplasms/genetics , Tumor Suppressor Proteins/metabolism , A Kinase Anchor Proteins/analysis , A Kinase Anchor Proteins/genetics , Aged , Cadherins/analysis , Cadherins/genetics , Carcinoma, Basal Cell/secondary , Cell Cycle Proteins/analysis , Cell Cycle Proteins/genetics , Down-Regulation , Female , Gene Expression , Humans , Immunohistochemistry , Intracellular Signaling Peptides and Proteins/analysis , Intracellular Signaling Peptides and Proteins/genetics , Kangai-1 Protein/analysis , Kangai-1 Protein/genetics , MAP Kinase Kinase 4/analysis , MAP Kinase Kinase 4/genetics , Male , Middle Aged , NM23 Nucleoside Diphosphate Kinases/analysis , NM23 Nucleoside Diphosphate Kinases/genetics , Skin/chemistry , Skin Neoplasms/pathology , Up-Regulation , rho Guanine Nucleotide Dissociation Inhibitor beta/analysis , rho Guanine Nucleotide Dissociation Inhibitor beta/genetics
12.
Oncotarget ; 5(17): 7392-405, 2014 Sep 15.
Article in English | MEDLINE | ID: mdl-25277180

ABSTRACT

We recently reported that low NM23-H1 expression of head and neck squamous cell carcinoma (HNSCC) correlated with poor patients' prognosis. Growing evidence has indicated that high tumor NM23-H1 expression contributes to a good response to chemotherapy. Therefore, we investigated the role of NM23-H1 in susceptibility of HNSCC cells to cisplatin and its clinical significance, as well as the in vitro study for validation was performed. Using immunohistochemistry, we analyzed NM23-H1 expression in surgical specimens from 46 HNSCC patients with cervical metastases receiving surgery and adjuvant chemoradiotherapy. Low tumor NM23-H1 expression correlated with locoregional recurrence of HNSCC following postoperative cisplatin-based therapy (p = 0.056) and poor patient prognosis (p = 0.001). To validate the clinical observation and the effect of NM23-H1 on cisplatin cytotoxicity, we established several stable clones derived from a human HNSCC cell line (SAS) by knockdown and overexpression. Knockdown of NM23-H1 attenuated the chemosensitivity of SAS cells to cisplatin, which was associated with reduced cisplatin-induced S-phase accumulation and downregulation of cyclin E1 and A. Overexpression of NM23-H1 reversed these results, indicating the essential role of NM23-H1 in treatment response to cisplatin. NM23-H1 may participate in HNSCC cell responses to cisplatin and be considered a potential therapeutic target.


Subject(s)
Biomarkers, Tumor/analysis , Carcinoma, Squamous Cell/pathology , Drug Resistance, Neoplasm/physiology , Head and Neck Neoplasms/pathology , NM23 Nucleoside Diphosphate Kinases/biosynthesis , Adult , Aged , Antineoplastic Agents/therapeutic use , Blotting, Western , Carcinoma, Squamous Cell/drug therapy , Carcinoma, Squamous Cell/metabolism , Cell Line, Tumor , Cisplatin/therapeutic use , Female , Flow Cytometry , Gene Knockdown Techniques , Head and Neck Neoplasms/drug therapy , Head and Neck Neoplasms/metabolism , Humans , Immunohistochemistry , Kaplan-Meier Estimate , Male , Middle Aged , NM23 Nucleoside Diphosphate Kinases/analysis , Proportional Hazards Models , Squamous Cell Carcinoma of Head and Neck , Transfection , Young Adult
13.
Indian J Pathol Microbiol ; 56(1): 2-5, 2013.
Article in English | MEDLINE | ID: mdl-23924549

ABSTRACT

CONTEXT: Thyroid cancer is the most common malignant endocrine tumor. Nowadays tissue biopsy and pathological assessment are the best diagnostic modalities for thyroid lesions. Differential diagnosis between adenomas and follicular variant of papillary thyroid carcinoma (PTC) is an important issue in pathology. AIMS: This study is designed to show any association between expressions of CD56 and nm23 and types of thyroid lesions (benign vs. malignant). SETTINGS AND DESIGN: In this cross-sectional study, 78 paraffin-embedded tissue blocks of thyroid tissue from a tertiary care center were selected, and assessed by using immunohistochemistry for expressions of CD56 and nm23 genes. MATERIALS AND METHODS: we studied 39 benign and 39 malignant thyroid lesions, CD56 and nm23 expressions were determined by immunohistochemical staining, and the results were used for differentiation of benign and malignant lesions of thyroid. STATISTICAL ANALYSIS: The obtained results were analyzed and evaluated using SPSS (Version 18). RESULTS: CD56 was expressed in 93% of benign specimens and in only 5% of malignant types. The sensitivity and specificity of this test were 94.8% and 92.3, respectively (P = 0.001). All malignant specimens and 95% of benign specimens were positive for nm23. The sensitivity and specificity of nm23 were 100% and 5%, respectively. CONCLUSION: Considering high sensitivity and specificity of CD56, it is possible to apply immunohistochemistry for definite diagnosis and differentiation of benign lesions from PTC. We conclude that by using this marker, the diagnostic mistakes in pathologic diagnosis of thyroid cancer versus benign lesions like thyroid adenoma will decrease.


Subject(s)
Biomarkers, Tumor/analysis , CD56 Antigen/analysis , Carcinoma/diagnosis , NM23 Nucleoside Diphosphate Kinases/analysis , Pathology/methods , Thyroid Neoplasms/diagnosis , Carcinoma/pathology , Carcinoma, Papillary , Cross-Sectional Studies , Female , Humans , Immunohistochemistry , Male , Microscopy , Sensitivity and Specificity , Thyroid Cancer, Papillary , Thyroid Neoplasms/pathology
14.
J BUON ; 18(2): 359-65, 2013.
Article in English | MEDLINE | ID: mdl-23818346

ABSTRACT

PURPOSE: To determine the prognostic significance of estrogen receptor (ER), progesterone receptor (PR), HER2/neu, Ki-67, and nm23 immunohistochemical expression with respect to progression free survival (PFS) and overall survival (OS) in Turkish patients with invasive breast cancer (IBC). METHODS: Patients with IBC (n = 81; mean age = 51.9 ± 11.1 years) were prospectively enrolled at the Department of Oncology, Uludag University Medical Center, Bursa, Turkey. Immunohistochemistry was performed on formalin- fixed, paraffin-embedded tissue sections. RESULTS: We did not find any significant association between immunohistochemical expression of ER, PR, HER2/ neu, Ki-67, and nm23 and the baseline characteristics of IBC patients. The median patient PFS was 30 months (range 22-45), and the median OS was 32 months (range 23-46). Stratification of the patient population according to nm23 immunohistochemical expression revealed a statistically significant difference in terms of both OS (p < 0.05) and DFS (p < 0.05). Multivariate Cox regression analysis indicated that tumor grade, axillary lymph node status, and nm23 immunohistochemical expression were the 3 main independent prognostic factors for PFS and OS in IBC patients. CONCLUSION: Reduced nm23 immunohistochemical expression is an independent negative prognostic factor for OS and PFS. Patients with negative nm23 expression may require a more intensive follow-up.


Subject(s)
Breast Neoplasms/chemistry , Carcinoma/chemistry , Ki-67 Antigen/analysis , NM23 Nucleoside Diphosphate Kinases/analysis , Receptor, ErbB-2/analysis , Receptors, Estrogen/analysis , Receptors, Progesterone/analysis , Adult , Breast Neoplasms/mortality , Breast Neoplasms/pathology , Breast Neoplasms/therapy , Carcinoma/mortality , Carcinoma/pathology , Carcinoma/therapy , Disease-Free Survival , Female , Humans , Immunohistochemistry , Kaplan-Meier Estimate , Middle Aged , Multivariate Analysis , Neoplasm Invasiveness , Predictive Value of Tests , Proportional Hazards Models , Prospective Studies , Risk Factors , Time Factors , Turkey
15.
Am J Dermatopathol ; 35(4): 452-7, 2013 Jun.
Article in English | MEDLINE | ID: mdl-23694823

ABSTRACT

Melanocytic nevus rests in lymph nodes are a known diagnostic challenge, especially in patients with a history of melanoma. Reticulin and NM23 have been studied in this context. The pattern of reticulin staining in melanomas surrounds groups/nests of melanocytes but individual cells in benign nevi. NM23, a metastasis-suppressor gene, has an association with metastatic potential in melanomas and some carcinomas. Twenty-eight cases (14 cases of metastatic melanoma to lymph nodes and 14 cases of lymph node nevus rests, all confirmed with Melan-A staining) were stained with reticulin and NM23. The pattern of reticulin staining was reported as surrounding groups if staining was noted in approximately 5-10 melanocytes in greater than 50% of the lesion but was otherwise reported as surrounding individual melanocytes. Cytoplasmic staining was considered to represent reactivity for NM23. Reticulin staining around groups of melanocytes was identified in all 14 cases of metastatic melanoma. Regarding nodal nevus rest cases, 12 of 14 cases (86%) demonstrated staining around individual melanocytes, whereas in 2 cases, reticulin surrounded melanocytic groups. NM23 staining was equivocal in all cases. Reticulin staining reliably invests groups of melanocytes in cases of metastatic melanoma, whereas in nodal nevus rests, it predominantly surrounds individual melanocytes. NM23 demonstrated no discriminatory value in this analysis. In cases in which a collection of melanocytes is present within a lymph node, reticulin deposition around individual melanocytes supports a diagnosis of lymph nodal nevus rest.


Subject(s)
Biomarkers, Tumor/analysis , Lymph Nodes/chemistry , Melanocytes/chemistry , Melanoma/chemistry , NM23 Nucleoside Diphosphate Kinases/analysis , Nevus, Pigmented/chemistry , Reticulin/analysis , Skin Neoplasms/chemistry , Aged , Biopsy , Female , Humans , Immunohistochemistry , Lymph Nodes/pathology , Lymphatic Metastasis , MART-1 Antigen/analysis , Male , Melanocytes/pathology , Melanoma/secondary , Nevus, Pigmented/pathology , Skin Neoplasms/pathology , United States
16.
Hepatogastroenterology ; 58(106): 558-64, 2011.
Article in English | MEDLINE | ID: mdl-21661431

ABSTRACT

BACKGROUND/AIMS: To investigate the effects of transcatheter arterial chemoembolization (TACE) on expression of nm23-H1 and TIMP-2 in the tumor tissue and prognosis of patients with hepatocellular carcinoma (HCC). METHODOLOGY: Seventy-two patients with resectable HCC were randomized into two equal groups with 36 patients in each: TACE before surgical resection of HCC (Group A) and direct surgical resection of HCC (Group B). All samples were subjected to pathological examination and immunohistochemical staining using nm23-H1 and TIMP-2 antibodies. Expression level and distribution of nm23-H1 and TIMP-2 in tumor and adjacent tissue were assessed. Extrahepatic metastasis and survival time of patients in both groups were evaluated through 36 months follow-up. RESULTS: Immunohistochemical analysis showed that the tumor tissues from patients in Group A had a higher positive expression of nm23-H1 than Group B (chi2=15.52, p<0.01). Group A also showed a higher positive expression of TIMP-2 than Group B (chi2=9.00, p<0.05). Patients in Group A had a longer mean survival time (36 vs. 28 months in Groups A and B, respectively) and higher survival rate (chi2=5.734, p=0.017). CONCLUSIONS: Preoperative TACE enhances the expression of metastasis suppressors nm23-H1 and TIMP-2, and may potentially inhibit metastasis of HCC and increase the survival time of patients with the resectable HCC.


Subject(s)
Carcinoma, Hepatocellular/therapy , Chemoembolization, Therapeutic , Liver Neoplasms/therapy , NM23 Nucleoside Diphosphate Kinases/analysis , Tissue Inhibitor of Metalloproteinase-2/analysis , Adult , Aged , Carcinoma, Hepatocellular/chemistry , Carcinoma, Hepatocellular/mortality , Female , Humans , Liver Neoplasms/chemistry , Liver Neoplasms/mortality , Male , Middle Aged , Multivariate Analysis , Prospective Studies , Survival Rate
17.
Clin Cancer Res ; 17(9): 2893-9, 2011 May 01.
Article in English | MEDLINE | ID: mdl-21478336

ABSTRACT

PURPOSE: We examined whether nm23-H1 is a prognostic factor of peripheral T-cell lymphoma, not otherwise specified (PTCL-NOS). EXPERIMENTAL DESIGN: We studied 102 consecutive, untreated PTCL-NOS patients from 1998 to 2008. The expression of nm23-H1 and TIA-1 was studied by immunohistochemistry. RESULTS: nm23-H1 was positive in 44.1% and TIA-1 in 78.4% of the PTCL-NOS patients. nm23-H1 expression was not correlated with age, performance status (PS), lactate dehydrogenase (LDH) level, or stage but was significantly correlated with the prognostic index for T-cell lymphoma. The serum nm23-H1 level was 43.44 ng/mL in the cytoplasmic nm23-H1 strongly positive, 24.32 ng/mL in the cytoplasmic nm23-H1 moderately positive, and 13.64 ng/mL in the cytoplasmic nm23-H1-negative patients. The nm23-H1-positive group had significantly shorter overall survival (OS). TIA-1 had no prognostic impact on 5-year OS rates. OS was significantly shorter in patients with the following clinicopathologic features: age 60 or more years, PS of 2 to 4, LDH level greater than normal, bone marrow involvement, or nm23-H1-positive lymphoma. Multivariate analysis confirmed nm23-H1 expression to be an independent prognostic factor. CONCLUSIONS: The nm23-H1 protein may be an important prognostic factor in PTCL-NOS. Because our results suggested that nm23-HI is produced by lymphoma cells, we expect to see the development of new treatments targeting nm23 overexpression.


Subject(s)
Lymphoma, T-Cell, Peripheral/diagnosis , NM23 Nucleoside Diphosphate Kinases/metabolism , Adult , Aged , Biomarkers, Tumor/analysis , Biomarkers, Tumor/blood , Biomarkers, Tumor/metabolism , Biomarkers, Tumor/physiology , Cytoplasm/metabolism , Cytoplasm/pathology , Humans , Lymphoma, T-Cell, Peripheral/blood , Lymphoma, T-Cell, Peripheral/metabolism , Lymphoma, T-Cell, Peripheral/mortality , Middle Aged , NM23 Nucleoside Diphosphate Kinases/analysis , NM23 Nucleoside Diphosphate Kinases/blood , NM23 Nucleoside Diphosphate Kinases/physiology , Prognosis , Survival Analysis
18.
J Proteomics ; 74(6): 874-86, 2011 May 16.
Article in English | MEDLINE | ID: mdl-21385632

ABSTRACT

Aiming to find new tumor markers for colorectal cancer (CRC), we applied proteomic methodologies to compare the soluble sub-proteome of healthy and tumoral colorectal mucosa. Out of 91 differentially expressed proteins, 23 were selected by principal component analysis (PCA) as the major contributors to the overall difference detected. After MS/MS analysis, 16 proteins were identified. From those, we chose 14-3-3-zeta/delta, retinoblastoma-binding protein 4 (RBBP-4), DJ-1, and nucleoside diphosphate kinase A (NDK A) for further studies, on the basis of their levels and known implication in cancer. Specific immunodetection demonstrated only the NDK A levels allowed to differentiate healthy mucosa from tumor tissue in all the patients. Hence, we used the colon cancer cell line Caco-2 to study the relationship between NDK A and colon cell tumorigenesis, finding it over-expressed in undifferentiated (tumor-like) cells regarding the differentiated ones. Noticeably, we also found increased levels of the NDK A in the secretome of tumor-like cells and, as expected, indications of higher levels of NDK A in the serum of CRC patients. In conclusion, the four validated proteins could constitute a panel of tissue markers for CRC, being the NDK A the most interesting candidate for further serum biomarker studies.


Subject(s)
Biomarkers, Tumor/analysis , Colorectal Neoplasms/diagnosis , NM23 Nucleoside Diphosphate Kinases/analysis , 14-3-3 Proteins/analysis , Adult , Aged , Aged, 80 and over , Caco-2 Cells , Female , Humans , Intestinal Mucosa/chemistry , Intracellular Signaling Peptides and Proteins/analysis , Male , Middle Aged , Oncogene Proteins/analysis , Principal Component Analysis , Protein Deglycase DJ-1 , Proteome/analysis , Retinoblastoma-Binding Protein 4/analysis , Tandem Mass Spectrometry
19.
Histopathology ; 57(4): 580-6, 2010 Oct.
Article in English | MEDLINE | ID: mdl-20955383

ABSTRACT

AIMS: To investigate the clinical role of nm23 expression in identifying both high-risk human papillomavirus (HR-HPV) and high-grade cervical lesions or carcinomas [cervical intraepithelial neoplasia 2(+) (CIN2(+) )], and to compare it with p16 overexpression, as this latter biomarker has already been reported widely in HR-HPV infected cervical lesions. METHODS AND RESULTS: Immunohistochemical evaluation of nm23 and p16 in 143 cervical biopsy specimens including negative, low- and high-grade lesions and squamous carcinomas (SC). HR-HPV testing by Digene hybrid capture 2 (HC2) and polymerase chain reaction (PCR) on the cervico-vaginal samples of the same patients. In detecting CIN2(+) , p16 was significantly more sensitive and specific than nm23 (96.3% versus 81.8% and 66% versus 36.4%, respectively, both P < 0.0001). Concerning HR-HPV detection by HC2, p16 showed a significantly higher specificity than nm23 (82% versus 47%, P <0.0001), although the sensitivities were comparable (71% versus 76%). We found a significantly direct correlation between nm23 and HC2 findings. However, nm23 expression did not correlate with HPV16/18 infection. In contrast, we observed a significant association between p16 overexpression and HPV16/18 genotypes. CONCLUSIONS: We confirm the diagnostic value of p16 overexpression. Moreover, despite in vitro data regarding the interaction with the HPV-E7 protein, nm23 does not appear to be a more useful biomarker than p16 in identifying CIN2(+) or HR-HPV infection.


Subject(s)
Biomarkers, Tumor/analysis , NM23 Nucleoside Diphosphate Kinases/analysis , Neoplasm Proteins/analysis , Uterine Cervical Dysplasia/pathology , Uterine Cervical Neoplasms/pathology , Adolescent , Adult , Aged , Biomarkers, Tumor/metabolism , Cyclin-Dependent Kinase Inhibitor p16 , Female , Humans , Immunohistochemistry , Middle Aged , NM23 Nucleoside Diphosphate Kinases/metabolism , Neoplasm Proteins/metabolism , Papillomavirus Infections/complications , Polymerase Chain Reaction , Risk Factors , Sensitivity and Specificity , Uterine Cervical Neoplasms/virology , Young Adult , Uterine Cervical Dysplasia/virology
20.
Zhong Nan Da Xue Xue Bao Yi Xue Ban ; 35(4): 286-94, 2010 Apr.
Article in English | MEDLINE | ID: mdl-20448348

ABSTRACT

OBJECTIVE: To study the proteins related to paclitaxel-resistant of ovarian cancer cell line. METHODS: The total proteins of paclitaxel-resistant and paclitaxel-sensitive human ovarian cancer cell lines were separated by 2-dimensional gel electrophoresis (2-DE). The differentially expressed proteins were analyzed using image analysis software. The differential proteins were identified using matrix-assisted laser desorption/ionization time-of-flight mass spectrometry. Western blot was used to determine the differential expression levels of the 2 proteins. RESULTS: Forty differentially expressed proteins were found by image analysis software, and 24 differential proteins were identified by mass spectrometry. These proteins included proliferation cell nuclear antigen (PCNA), nm23, prohibitin (PHB), annexin, alpha-enolase, heat shock protein (HSP), and so on. CONCLUSION: Twenty-four proteins in human ovarian cancer cell lines of paclitaxel-resistant and paclitaxel-sensitive are found by proteomic techniques, which may be involved in the paclitaxel-resistance of human ovarian cancer cells.


Subject(s)
Drug Resistance, Neoplasm/genetics , Ovarian Neoplasms/metabolism , Paclitaxel/pharmacology , Proteome/analysis , Proteomics/methods , Antineoplastic Agents, Phytogenic/pharmacology , Cell Line, Tumor , Electrophoresis, Gel, Two-Dimensional , Female , Humans , NM23 Nucleoside Diphosphate Kinases/analysis , Ovarian Neoplasms/genetics , Ovarian Neoplasms/pathology , Prohibitins , Proliferating Cell Nuclear Antigen/analysis , Repressor Proteins/analysis
SELECTION OF CITATIONS
SEARCH DETAIL
...